Xconomy’s Digital Events →
John Maraganore explained the past and present of Alnylam’s RNAi quest, and had some pointed remarks for pharma as well.
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
From Our Editors · Podcast
Becoming the Cell & Gene Therapy Hub
What the most successful life sciences fundraising pitch decks all have in common
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.